The CADD Symposium will be held on Thursday, May 25, 2023, at the University of Maryland School of Pharmacy in Pharmacy Hall, Room N103. The symposium is primarily an in-person event. However, it will be possible to participate in the lecture portion of the symposium virtually.
About the Event:
This symposium is designed to facilitate collaborations between the CADD Center at the School of Pharmacy and researchers at UMB, throughout the University System of Maryland, and beyond. The symposium is appropriate for all scientists interested in the field of drug design involving both small molecules and protein-based drugs, including graduate students, postdoctoral fellows, and researchers and educators from academia, government, and industry. A collection of local and external speakers, including computational chemists and experimentalists, will present recent developments in drug design and development, as well as emerging areas of biology that may represent future drug discovery targets.
The symposium is free to attend, but registration is required. Registration is now closed.
Space is also available for attendees to present posters. Poster submission may be completed while registering for the meeting. Attendees may also submit a poster after registering or submit a second poster by visiting this webpage.
About the Sponsors:
|The University of Maryland School of Pharmacy, the fourth oldest school of pharmacy in the United States, leads pharmacy education, scientific discovery, patient care, and community engagement in the state of Maryland and beyond.
|SilcsBio provides software and services for unlocking the full potential of computer driven drug design. Its algorithms for mapping proteins offer a level of detail that has never before been seen. From its highly accurate free energy maps to conformational nuances revealing hidden pockets of opportunity, SilcsBio uncovers a whole new world of possibilities
|Early Charm Ventures creates, owns, and operates businesses that convert science into revenue. We are the management team, the operators, and the entrepreneurs. We don’t write checks and just pop in for board meetings. We show up to our labs, our production facilities, and our offices every day to do all the heavy lifting in our portfolio companies.
|Rasio Therapeutics, Inc., a Maryland-based drug development company, creates novel medicines using a cutting edge-computer aided drug design technology. Our mission addresses unmet patient needs through modeling of novel/deep cell binding regions. Rasio designs and develops molecules to fit those regions and enhance treatment for cancer and other diseases.